BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35468719)

  • 1. 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.
    Herber CB; Yuan C; Chang A; Wang JC; Cohen I; Leitman DC
    Mol Med; 2022 Apr; 28(1):44. PubMed ID: 35468719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
    Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
    Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG; Secreto FJ; Subramaniam M; Getz BJ; Khosla S; Spelsberg TC
    Mol Endocrinol; 2005 Jun; 19(6):1555-68. PubMed ID: 15802376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
    Madak-Erdogan Z; Gong P; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
    Messier TL; Boyd JR; Gordon JAR; Tye CE; Page NA; Toor RH; Zaidi SK; Komm BS; Frietze S; Stein JL; Lian JB; Stein GS
    PLoS One; 2022; 17(7):e0271725. PubMed ID: 35862394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
    Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
    Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative Properties of 17β-aminoestrogens in MCF-7 Human Breast Cancer Cells.
    Lemini C; Estela Avila M; Medina M; Sánchez C; Figueroa A; García-Mondragón MJ; Vargas-Vázquez A; Jiménez-Orozco A
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):235-242. PubMed ID: 27638561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists.
    Leitman DC; Paruthiyil S; Vivar OI; Saunier EF; Herber CB; Cohen I; Tagliaferri M; Speed TP
    Curr Opin Pharmacol; 2010 Dec; 10(6):629-36. PubMed ID: 20951642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
    Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.
    Farooqui M; Geng ZH; Stephenson EJ; Zaveri N; Yee D; Gupta K
    Mol Cancer Ther; 2006 Mar; 5(3):611-20. PubMed ID: 16546975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.
    Lin Z; Yin P; Reierstad S; O'Halloran M; Coon VJ; Pearson EK; Mutlu GM; Bulun SE
    Oncogene; 2010 Feb; 29(8):1114-22. PubMed ID: 19935720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.